FDA Overreach on Hold, Temporarily
The FDA has delayed implementation of a bad rule that will limit access to customized medicines like bioidentical estriol and progesterone that millions of women rely on. The FDA recently announced that it will extend by one year — to October 27, 2022 — the date on which it will begin enforcement of the Memorandum […]









